The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward.
Saved in:
| Title: | The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward. |
|---|---|
| Authors: | SALONER, BRENDAN (AUTHOR) |
| Source: | Milbank Quarterly. 2025 Suppl 1, Vol. 103, p280-296. 17p. |
| Subjects: | Substance abuse treatment, Mental health laws, Drug overdose, Risk assessment, Government policy, Diffusion of innovations, Health insurance reimbursement, Insurance, Medical quality control, Medical care, Primary health care, Affinity groups, Value-based healthcare, Continuum of care, Psychological adaptation, Goal (Psychology), Health care reform, Reward (Psychology), Contingency management, Eligibility (Social aspects), Convalescence, Medicaid, Needs assessment, Housing, Budget, Practical politics, Patient Protection & Affordable Care Act, Integrated health care delivery, Government regulation, Employment, Disease risk factors, History |
| Abstract: | Policy PointsThe role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits.Current innovations in SUD treatment focus on expanding the delivery system to create a comprehensive continuum of care, using more value‐based payment to reward quality care, and integrating SUD treatment with other systems (e.g., housing, employment, and the criminal legal system).Many of the promising innovations in delivery have not yet been rigorously studied, and implementation of effective models is often stymied because of the lack of flexibility in program requirements and variation in needs and resources across communities.Although policymakers can justifiably laud the great strides Medicaid has made in raising the standards for SUD treatment, there is a huge remaining gap in access to services amidst an unprecedented overdose crisis and looming turmoil in the program. [ABSTRACT FROM AUTHOR] |
| Copyright of Milbank Quarterly is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Policy PointsThe role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits.Current innovations in SUD treatment focus on expanding the delivery system to create a comprehensive continuum of care, using more value‐based payment to reward quality care, and integrating SUD treatment with other systems (e.g., housing, employment, and the criminal legal system).Many of the promising innovations in delivery have not yet been rigorously studied, and implementation of effective models is often stymied because of the lack of flexibility in program requirements and variation in needs and resources across communities.Although policymakers can justifiably laud the great strides Medicaid has made in raising the standards for SUD treatment, there is a huge remaining gap in access to services amidst an unprecedented overdose crisis and looming turmoil in the program. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 0887378X |
| DOI: | 10.1111/1468-0009.70007 |
